vitamin-k-1 and Aneurysm--False

vitamin-k-1 has been researched along with Aneurysm--False* in 1 studies

Other Studies

1 other study(ies) available for vitamin-k-1 and Aneurysm--False

Article	Year
[Reversal of acenocoumarol anticoagulation with activated factor VII in massive hemorrhage following rupture of a splenic artery pseudoaneurysm]. Revista espanola de anestesiologia y reanimacion, 2009, Volume: 56, Issue:4 A 66-year-old man with a metallic valve and under treatment with acenocoumarol developed hypovolemic shock after rupture of a splenic artery pseudoaneurysm. We managed to reverse anticoagulation within 60 minutes by administering 20 mg of vitamin K and 4.8 mg of activated recombinant factor VII. No thromboembolic adverse events were observed. We discuss the pharmacologic effects of coumarin derivatives and their antagonists, as well as the use of activated factor VII in the reversal of anticoagulation by these drugs. Topics: Acenocoumarol; Aged; Aneurysm, False; Anticoagulants; Combined Modality Therapy; Crystalloid Solutions; Drug Therapy, Combination; Embolization, Therapeutic; Erythrocyte Transfusion; Factor VIIa; Heart Valve Prosthesis; Hemoperitoneum; Humans; Isotonic Solutions; Male; Recombinant Proteins; Rupture, Spontaneous; Splenic Artery; Vitamin K 1	2009

Article

Year

[Reversal of acenocoumarol anticoagulation with activated factor VII in massive hemorrhage following rupture of a splenic artery pseudoaneurysm].

Revista espanola de anestesiologia y reanimacion, 2009, Volume: 56, Issue:4

A 66-year-old man with a metallic valve and under treatment with acenocoumarol developed hypovolemic shock after rupture of a splenic artery pseudoaneurysm. We managed to reverse anticoagulation within 60 minutes by administering 20 mg of vitamin K and 4.8 mg of activated recombinant factor VII. No thromboembolic adverse events were observed. We discuss the pharmacologic effects of coumarin derivatives and their antagonists, as well as the use of activated factor VII in the reversal of anticoagulation by these drugs.

Topics: Acenocoumarol; Aged; Aneurysm, False; Anticoagulants; Combined Modality Therapy; Crystalloid Solutions; Drug Therapy, Combination; Embolization, Therapeutic; Erythrocyte Transfusion; Factor VIIa; Heart Valve Prosthesis; Hemoperitoneum; Humans; Isotonic Solutions; Male; Recombinant Proteins; Rupture, Spontaneous; Splenic Artery; Vitamin K 1

2009